No Data
West Point Pharmaceutical (301130.SZ): The company currently has Traditional Chinese Medicine products such as Xin Nao Kang capsules and Jiang Tang Ning capsules.
On January 9, Gelonghui reported that Western Point Pharmaceuticals (301130.SZ) disclosed the investor relations activity record showing that Traditional Chinese Medicine products are an important aspect of the company's Global Strategy layout. The company currently owns Traditional Chinese Medicine products such as Xin Naokang capsules, Jiangtangning capsules, Yigan Fuzheng capsules, Yigan Jiedu capsules, and Sanqi tablets. The company is actively laying out the big health product field through its wholly-owned subsidiary, Western Point (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd., reorganizing existing reserve projects and accelerating the progress of projects aligned with the company's Global Strategy.
Express News | Pharma stocks rebounded in the morning, with Guangdong Hybribio Biotech soaring nearly 14%, while Tellgen Corporation, West Point Pharmaceutical, and Shandong Lukang Pharmaceutical strengthened in the short term.
Express News | Today, a total of 46 individual stocks in the A-share market experienced block trades, with Dongguan Dingtong Precision Metal Co.,Ltd., Runben Co., and Industrial And Commercial Bank Of China leading in transaction volume.
Express News | Midday announcement: Xiaoming Co., Ltd. reported a month-on-month increase of 7.36% in chicken product sales revenue for November.
Express News | West Point Pharmaceutical: The application for supplementary approval of the oral solution of levocetirizine dihydrochloride has been approved.
The main shareholder of West Point Pharmaceutical (301130.SZ), Guotou Gaoke and its concerted actors have cumulatively reduced their shareholding by 1.03%.
West Point Pharmaceutical (301130.SZ) announced that the shareholder holding more than 5% of the company is China Investment Corporation High Technology Investment Co., Ltd.
